Stay updated on Inhaled GB002 for PAH: Phase III Clinical Trial
Sign up to get notified when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.

Latest updates to the Inhaled GB002 for PAH: Phase III Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe new screenshot adds Revision: v3.3.3 in the footer and removes HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedOnly a revision tag on the page changed, updating from v3.3.1 to v3.3.2; no study data or statuses were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page history shows an added revision entry (v3.3.1) and a removed entry (v3.2.0), which are routine updates to the revision log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedDifference0.6%

- Check59 days agoChange DetectedThe new version shows updates to the Study Status and related Contacts/Locations in the version history for NCT03926793, indicating ongoing changes to the trial's status. No other major content removals or additions are evident in this view.SummaryDifference0.1%

- Check88 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference11%

Stay in the know with updates to Inhaled GB002 for PAH: Phase III Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.